HIGHLIGHTS
- who: Lei She from the Yale University, United States have published the research: Bevacizumab combined with re-irradiation in recurrent glioblastoma, in the Journal: (JOURNAL)
- what: The aim this study was to evaluate the safety tolerability and efficacy a combination BEV and re-RT for rGBM treatment. In this study, all analyses were based on the whole cohort and no further stratification of rGBM was explored.
- how: In comparison with these studies in the study BEV was used in both concurrent and maintenance modalities.
- future: Investigations are needed to verify this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.